Showing results (461-470 of 689) with videos related to

Sort By:
Pageof 69
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2019
Targeting ABL1 or ARG Tyrosine Kinases to Restrict HIV-1 Infection in Primary CD4+ T-Cells or in Humanized NSG MiceStephen D S McCarthy, Danila Leontyev, Pauline Nicoletti, et al.
Plos Neglected Tropical Diseases|March 3, 2015
Prospective study in a porcine model of sarcoptes scabiei indicates the association of Th2 and Th17 pathways with the clinical severity of scabiesKate E Mounsey, Hugh C Murray, Helle Bielefeldt-Ohmann, et al.
Research in Social & Administrative Pharmacy : RSAP|May 10, 2014
Exploring pharmacists' opinions regarding PHARMAC's interventions in promoting brand changesZ U Babar, A Polwin, S W Kan, et al.
The Yale Journal of Biology and Medicine|July 1, 1986
Computed tomographic (CT) guided percutaneous fine-needle aspiration biopsy: the Yale experienceL W Hammers, S McCarthy, H Williams, et al.
Molecular and Biochemical Parasitology|March 13, 1998
Onchocera volvulus: characterization of a highly immunogenic Gln-rich proteinG T Joseph, J S McCarthy, T Huima, et al.
The Journal of Infectious Diseases|June 2, 2020
Antimalarial Activity of Artefenomel Against Asexual Parasites and Transmissible Gametocytes During Experimental Blood-Stage Plasmodium vivax InfectionKatharine A Collins, Azrin N Abd-Rahman, Louise Marquart, et al.
Epidemiology and Infection|October 25, 2007
Skin infections among Indigenous Australians in an urban setting in far North QueenslandP C Valery, M Wenitong, V Clements, et al.
Malaria Journal|April 11, 2021
Analytical validation of a real-time hydrolysis probe PCR assay for quantifying Plasmodium falciparum parasites in experimentally infected human adultsClaire Y T Wang, Emma L Ballard, Zuleima Pava, et al.
JCI Insight|August 4, 2017
Dichotomous miR expression and immune responses following primary blood-stage malariaJulie G Burel, Simon H Apte, Penny L Groves, et al.
The Journal of Antimicrobial Chemotherapy|June 28, 2021
Seeking an optimal dosing regimen for OZ439/DSM265 combination therapy for treating uncomplicated falciparum malariaSaber Dini, Sophie G Zaloumis, David J Price, et al.
Pageof 69